Skip to content

Drug interactions

Encorafenib + Sirolimus

Severity: Moderate

Encorafenib and Sirolimus: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Encorafenib both inhibits and induces CYP3A4, so sirolimus exposure may rise or fall unpredictably. Subtherapeutic levels risk rejection, while high levels increase toxicity.

What this interaction means in plain words

Encorafenib and Sirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Encorafenib belongs to Oncology; Sirolimus belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Mixed inhibition and induction of CYP3A4 by encorafenib alters sirolimus metabolism.

What to do

Monitor sirolimus trough concentrations frequently after starting, changing or stopping encorafenib, and adjust the sirolimus dose to the target range.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Encorafenib and Sirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Encorafenib with Sirolimus?

MediHelp rates the interaction as moderate. Encorafenib and Sirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Encorafenib both inhibits and induces CYP3A4, so sirolimus exposure may rise or fall unpredictably. Subtherapeutic levels risk rejection, while high levels increase toxicity.

How serious is the interaction between Encorafenib and Sirolimus?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor sirolimus trough concentrations frequently after starting, changing or stopping encorafenib, and adjust the sirolimus dose to the target range.

What other medicines interact with Sirolimus?

MediHelp also lists interactions of Sirolimus with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Sirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in